2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope
Tóm tắt
Từ khóa
Tài liệu tham khảo
Moya, 2009, Guidelines for the diagnosis and management of syncope (version 2009), Eur Heart J, 30, 2631, 10.1093/eurheartj/ehp298
Olshansky, 2013, Inappropriate sinus tachycardia, J Am Coll Cardiol, 61, 793, 10.1016/j.jacc.2012.07.074
Brignole, 2012, New concepts in the assessment of syncope, J Am Coll Cardiol, 59, 1583, 10.1016/j.jacc.2011.11.056
Jacobs, 2014, The evolution and future of ACC/AHA clinical practice guidelines: a 30–year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 64, 1373, 10.1016/j.jacc.2014.06.001
Thieben, 2007, Postural orthostatic tachycardia syndrome: the Mayo clinic experience, Mayo Clin Proc, 82, 308, 10.1016/S0025-6196(11)61027-6
Schondorf, 1993, Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia?, Neurology, 43, 132, 10.1212/WNL.43.1_Part_1.132
Low, 1995, Postural tachycardia syndrome (POTS), Neurology, 45, S19
Freeman, 2011, Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome, Auton Neurosci, 161, 46, 10.1016/j.autneu.2011.02.004
Singer, 2012, Postural tachycardia in children and adolescents: what is abnormal?, J Pediatr, 160, 222, 10.1016/j.jpeds.2011.08.054
Garland, 2007, The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome, Neurology, 69, 790, 10.1212/01.wnl.0000267663.05398.40
Low, 2009, Postural tachycardia syndrome (POTS), J Cardiovasc Electrophysiol, 20, 352, 10.1111/j.1540-8167.2008.01407.x
Robertson, 1999, The epidemic of orthostatic tachycardia and orthostatic intolerance, Am J Med Sci, 317, 75, 10.1016/S0002-9629(15)40480-X
Schondorf, 1999, Orthostatic intolerance in the chronic fatigue syndrome, J Auton Nerv Syst, 75, 192, 10.1016/S0165-1838(98)00177-5
Freeman, 2011, Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome, Clin Auton Res, 21, 69, 10.1007/s10286-011-0119-5
Lewis, 2013, Clinical characteristics of a novel subgroup of chronic fatigue syndrome patients with postural orthostatic tachycardia syndrome, J Intern Med, 273, 501, 10.1111/joim.12022
Benarroch, 2012, Postural tachycardia syndrome: a heterogeneous and multifactorial disorder, Mayo Clin Proc, 87, 1214, 10.1016/j.mayocp.2012.08.013
Peltier, 2010, Distal sudomotor findings in postural tachycardia syndrome, Clin Auton Res, 20, 93, 10.1007/s10286-009-0045-y
Singer, 2004, Prospective evaluation of somatic and autonomic small fibers in selected autonomic neuropathies, Neurology, 62, 612, 10.1212/01.WNL.0000110313.39239.82
Low, 1994, Comparison of the postural tachycardia syndrome (POTS) with orthostatic hypotension due to autonomic failure, J Auton Nerv Syst, 50, 181, 10.1016/0165-1838(94)90008-6
Vogel, 2005, Blood pressure recovery from Valsalva maneuver in patients with autonomic failure, Neurology, 65, 1533, 10.1212/01.wnl.0000184504.13173.ef
Sandroni, 2000, Mechanisms of blood pressure alterations in response to the Valsalva maneuver in postural tachycardia syndrome, Clin Auton Res, 10, 1, 10.1007/BF02291382
Jacob, 2000, The neuropathic postural tachycardia syndrome, N Engl J Med, 343, 1008, 10.1056/NEJM200010053431404
Stewart, 2004, Decreased skeletal muscle pump activity in patients with postural tachycardia syndrome and low peripheral blood flow, Am J Physiol Heart Circ Physiol, 286, H1216, 10.1152/ajpheart.00738.2003
Stewart, 2006, Persistent splanchnic hyperemia during upright tilt in postural tachycardia syndrome, Am J Physiol Heart Circ Physiol, 290, H665, 10.1152/ajpheart.00784.2005
Stewart, 2004, Regional blood volume and peripheral blood flow in postural tachycardia syndrome, Am J Physiol Heart Circ Physiol, 287, H1319, 10.1152/ajpheart.00086.2004
Tani, 1999, Splanchnic and systemic circulation in the postural tachycardia syndrome, Clin Auton Res, 9, 231
Wallman, 2014, Ehlers-Danlos Syndrome and Postural Tachycardia Syndrome: a relationship study, J ournal Neurol Sci, 340, 99, 10.1016/j.jns.2014.03.002
Wang, 2013, Autoimmunoreactive IgGs against cardiac lipid raft-associated proteins in patients with postural orthostatic tachycardia syndrome, Transl Res, 162, 34, 10.1016/j.trsl.2013.03.002
Li, 2014, Autoimmune basis for postural tachycardia syndrome, JAMA, 3, e000755
Raj, 2005, Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome, Circulation, 111, 1574, 10.1161/01.CIR.0000160356.97313.5D
Abe, 2000, Heart rate and plasma cyclic AMP responses to isoproterenol infusion and effect of beta-adrenergic blockade in patients with postural orthostatic tachycardia syndrome, J Cardiovasc Pharmacol, 36, S79, 10.1097/00005344-200000006-00017
Parsaik, 2012, Deconditioning in patients with orthostatic intolerance, Neurology, 79, 1435, 10.1212/WNL.0b013e31826d5f95
Fu, 2010, Cardiac origins of the postural orthostatic tachycardia syndrome, J Am Coll Cardiol, 55, 2858, 10.1016/j.jacc.2010.02.043
Masuki, 2007, Excessive heart rate response to orthostatic stress in postural tachycardia syndrome is not caused by anxiety, J Appl Physiol, 102, 896, 10.1152/japplphysiol.00927.2006
Benrud-Larson, 2003, Correlates of functional disability in patients with postural tachycardia syndrome: preliminary cross-sectional findings, Health Psychol, 22, 643, 10.1037/0278-6133.22.6.643
Winker, 2005, Endurance exercise training in orthostatic intolerance: a randomized, controlled trial, Hypertension, 45, 391, 10.1161/01.HYP.0000156540.25707.af
Rowe, 2001, Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial, JAMA, 285, 52, 10.1001/jama.285.1.52
Jacob, 1997, Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia, Circulation, 96, 575, 10.1161/01.CIR.96.2.575
Gordon, 2000, Hemodynamic and symptomatic effects of acute interventions on tilt in patients with postural tachycardia syndrome, Clin Auton Res, 10, 29, 10.1007/BF02291387
Raj, 2009, Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more, Circulation, 120, 725, 10.1161/CIRCULATIONAHA.108.846501
Fu, 2011, Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome, Hypertension, 58, 167, 10.1161/HYPERTENSIONAHA.111.172262
McDonald, 2011, Single centre experience of ivabradine in postural orthostatic tachycardia syndrome, Europace, 13, 427, 10.1093/europace/euq390
Raj, 2005, Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome, Circulation, 111, 2734, 10.1161/CIRCULATIONAHA.104.497594
Kanjwal, 2011, Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience, Pacing Clin Electrophysiol, 34, 750, 10.1111/j.1540-8159.2011.03047.x
Gaffney, 1983, Effects of long-term clonidine administration on the hemodynamic and neuroendocrine postural responses of patients with dysautonomia, Chest, 83, 436, 10.1378/chest.83.2.436
Shibao, 2005, Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders, Hypertension, 45, 385, 10.1161/01.HYP.0000158259.68614.40
Taneja, 2004, Effect of modafinil on acute pain: a randomized double-blind crossover study, J Clin Pharmacol, 44, 1425, 10.1177/0091270004270292
Shen, 2001, Is sinus node modification appropriate for inappropriate sinus tachycardia with features of postural orthostatic tachycardia syndrome?, Pacing Clin Electrophysiol, 24, 217, 10.1046/j.1460-9592.2001.00217.x
Garland, 2001, Chiari I malformation as a cause of orthostatic intolerance symptoms: a media myth?, Am J Med, 111, 546, 10.1016/S0002-9343(01)00922-6
Prilipko, 2005, Orthostatic intolerance and syncope associated with Chiari type I malformation, J Neurol Neurosurg Psychiatry, 76, 1034, 10.1136/jnnp.2004.048330
Still, 2005, Prevalence, characteristics and natural course of inappropriate sinus tachycardia, Europace, 7, 104, 10.1016/j.eupc.2004.12.007
Chiale, 2006, Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac beta adrenergic receptors, Heart Rhythm, 3, 1182, 10.1016/j.hrthm.2006.06.011
Winum, 2009, A case of cardiomyopathy induced by inappropriate sinus tachycardia and cured by ivabradine, Pacing Clin Electrophysiol, 32, 942, 10.1111/j.1540-8159.2009.02414.x
Romeo, 2011, A pediatric case of cardiomyopathy induced by inappropriate sinus tachycardia: efficacy of ivabradine, Pediatr Cardiol, 32, 842, 10.1007/s00246-011-9964-1
Brady, 2005, Inappropriate sinus tachycardia, postural orthostatic tachycardia syndrome, and overlapping syndromes, Pacing Clin Electrophysiol, 28, 1112, 10.1111/j.1540-8159.2005.00227.x
Ewing, 1974, Cardiovascular responses to sustained handgrip in normal subjects and in patients with diabetes mellitus: a test of autonomic function, Clin Sci Mol Med, 46, 295
Morillo, 1994, Mechanism of ”inappropriate” sinus tachycardia. Role of sympathovagal balance, Circulation, 90, 873, 10.1161/01.CIR.90.2.873
Castellanos, 1998, Heart rate variability in inappropriate sinus tachycardia, Am J Cardiol, 82, 531, 10.1016/S0002-9149(98)00373-7
Leon, 2005, Impaired baroreflex gain in patients with inappropriate sinus tachycardia, J Cardiovasc Electrophysiol, 16, 64, 10.1046/j.1540-8167.2005.04441.x
Marrouche, 2002, Three-dimensional nonfluoroscopic mapping and ablation of inappropriate sinus tachycardia. Procedural strategies and long-term outcome, J Am Coll Cardiol, 39, 1046, 10.1016/S0735-1097(02)01703-5
Cappato, 2012, Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation, J oAm Coll Cardiol, 60, 1323, 10.1016/j.jacc.2012.06.031
Ptaszynski, 2013, Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia, J Cardiovasc Pharmacol Ther, 18, 338, 10.1177/1074248413478172
Ganzeboom, 2006, Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35–60 years, J Cardiovasc Electrophysiol, 17, 1172, 10.1111/j.1540-8167.2006.00595.x
Serletis, 2006, Vasovagal syncope in medical students and their first-degree relatives, Eur Heart J, 27, 1965, 10.1093/eurheartj/ehl147
Sheldon, 2006, Investigators of the Syncope Symptom Study and the Prevention of Syncope Trial. Age of first faint in patients with vasovagal syncope, J Cardiovasc Electrophysiol, 17, 49, 10.1111/j.1540-8167.2005.00267.x
Sumner, 2010, Prevention of Syncope Trial I. Recent history of vasovagal syncope in a young, referral-based population is a stronger predictor of recurrent syncope than lifetime syncope burden, J Cardiovasc Electrophysiol, 21, 1375, 10.1111/j.1540-8167.2010.01848.x
Chen, 2003, Prevalence and clinical outcomes of patients with multiple potential causes of syncope, Mayo Clin Proc, 78, 414, 10.4065/78.4.414
Brignole, 2006, A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals, Eur Heart J, 27, 76, 10.1093/eurheartj/ehi647
D’Ascenzo, 2013, Incidence, etiology and predictors of adverse outcomes in 43,315 patients presenting to the Emergency Department with syncope: an international meta-analysis, Int J Cardiol, 167, 57, 10.1016/j.ijcard.2011.11.083
Barón-Esquivias, 2004, Long-term outcome of patients with vasovagal syncope, Am Heart J, 147, 83, 10.1016/j.ahj.2003.11.022
Mosqueda-Garcia, 2000, The elusive pathophysiology of neurally mediated syncope, Circulation, 102, 2898, 10.1161/01.CIR.102.23.2898
Glick, 1963, Hemodynamic changes during spontaneous vasovagal reactions, Am J Med, 34, 42, 10.1016/0002-9343(63)90037-8
Hargreaves, 1992, Lack of variation in venous tone potentiates vasovagal syncope, Br Heart J, 67, 486, 10.1136/hrt.67.6.486
Manyari, 1996, Abnormal reflex venous function in patients with neuromediated syncope, J Am Coll Cardiol, 27, 1730, 10.1016/0735-1097(96)00051-4
Thomson, 1996, Failure of reflex venoconstriction during exercise in patients with vasovagal syncope, Circulation, 93, 953, 10.1161/01.CIR.93.5.953
Verheyden, 2008, Steep fall in cardiac output is main determinant of hypotension during drug-free and nitroglycerine-induced orthostatic vasovagal syncope, Heart Rhythm, 5, 1695, 10.1016/j.hrthm.2008.09.003
Gisolf, 2004, Sublingual nitroglycerin used in routine tilt testing provokes a cardiac output-mediated vasovagal response, J Am Coll Cardiol, 44, 588, 10.1016/j.jacc.2004.04.038
Verheyden, 2007, Impact of age on the vasovagal response provoked by sublingual nitroglycerine in routine tilt testing, Clin Sci, 113, 329, 10.1042/CS20070042
Fu, 2014, Pathophysiology of neurally mediated syncope: Role of cardiac output and total peripheral resistance, Auton Neurosci, 184, 24, 10.1016/j.autneu.2014.07.004
Morillo, 1997, Vagal and sympathetic mechanisms in patients with orthostatic vasovagal syncope, Circulation, 96, 2509, 10.1161/01.CIR.96.8.2509
Mosqueda-Garcia, 1997, Sympathetic and baroreceptor reflex function in neurally mediated syncope evoked by tilt, J Clin Invest, 99, 2736, 10.1172/JCI119463
Jardine, 2002, Decrease in cardiac output and muscle sympathetic activity during vasovagal syncope, Am J Physiol Heart Circ Physiol, 282, H1804, 10.1152/ajpheart.00640.2001
Cooke, 2002, Association between vasovagal hypotension and low sympathetic neural activity during presyncope, Clin Auton Res, 12, 483, 10.1007/s10286-002-0057-3
Vaddadi, 2010, Persistence of muscle sympathetic nerve activity during vasovagal syncope, Eur Heart J, 31, 2027, 10.1093/eurheartj/ehq071
Vaddadi, 2011, Recurrent postural vasovagal syncope: sympathetic nervous system phenotypes, Circ Arrhythm Electrophysiol, 4, 711, 10.1161/CIRCEP.111.962332
Sheldon, 2013, How to differentiate syncope from seizure, Card Electrophysiol Clin, 5, 423, 10.1016/j.ccep.2013.08.004
van Dijk, 2008, High diagnostic yield and accuracy of history, physical examination, and ECG in patients with transient loss of consciousness in FAST: the Fainting Assessment study, J Cardiovasc Electrophysiol, 19, 48, 10.1111/j.1540-8167.2007.00984.x
Sheldon, 2010, Syncope and structural heart disease: historical criteria for vasovagal syncope and ventricular tachycardia, J Cardiovasc Electrophysiol, 21, 1358, 10.1111/j.1540-8167.2010.01835.x
Sheldon, 2006, Diagnostic criteria for vasovagal syncope based on a quantitative history, Eur Heart J, 27, 344, 10.1093/eurheartj/ehi584
Sheldon, 2002, Historical criteria that distinguish syncope from seizures, J Am Coll Cardiol, 40, 142, 10.1016/S0735-1097(02)01940-X
Sheldon, 1998, Electroencephalographic findings during presyncope and syncope induced by tilt table testing, Can J Cardiol, 14, 811
Romme, 2009, Diagnosing vasovagal syncope based on quantitative history-taking: validation of the Calgary Syncope Symptom Score, Eur Heart J, 30, 2888, 10.1093/eurheartj/ehp314
Exposito, 2013, Usefulness of the Calgary Syncope Symptom Score for the diagnosis of vasovagal syncope in the elderly, Europace, 15, 1210, 10.1093/europace/eut042
Alboni, 2001, Diagnostic value of history in patients with syncope with or without heart disease, J Am Coll Cardiol, 37, 1921, 10.1016/S0735-1097(01)01241-4
Sud, 2009, Predicting the cause of syncope from clinical history in patients undergoing prolonged monitoring, Heart Rhythm, 6, 238, 10.1016/j.hrthm.2008.10.035
Natale, 1995, Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope, Circulation, 92, 54, 10.1161/01.CIR.92.1.54
Del Rosso, 2008, Clinical predictors of cardiac syncope at initial evaluation in patients referred urgently to a general hospital: the EGSYS score, Heart, 94, 1620, 10.1136/hrt.2008.143123
Rafanelli, 2014, Clinical aspects and diagnostic relevance of neuroautonomic evaluation in patients with unexplained falls, Aging Clin Exp Res, 26, 33, 10.1007/s40520-013-0124-8
Blanc, 2013, Clinical laboratory testing: what is the role of tilt-table testing, active standing test, carotid massage, electrophysiological testing and ATP test in the syncope evaluation?, Prog Cardiovasc Dis, 55, 418, 10.1016/j.pcad.2012.11.002
Farwell, 2006, The clinical impact of implantable loop recorders in patients with syncope, Eur Heart J, 27, 351, 10.1093/eurheartj/ehi602
Krahn, 2003, Cost implications of testing strategy in patients with syncope: randomized assessment of syncope trial, J Am Coll Cardiol, 42, 495, 10.1016/S0735-1097(03)00659-4
Krahn, 1998, Final results from a pilot study with an implantable loop recorder to determine the etiology of syncope in patients with negative noninvasive and invasive testing, Am J Cardiol, 82, 117, 10.1016/S0002-9149(98)00237-9
Krahn, 1995, The etiology of syncope in patients with negative tilt table and electrophysiological testing, Circulation, 92, 1819, 10.1161/01.CIR.92.7.1819
Krahn, 1999, Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators, Circulation, 99, 406, 10.1161/01.CIR.99.3.406
Moya, 2001, International Study on Syncope of Uncertain Etiology (ISSUE) Investigators. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope, Circulation, 104, 1261, 10.1161/hc3601.095708
Moya, 2008, Reproducibility of electrocardiographic findings in patients with suspected reflex neurally-mediated syncope, Am J Cardiol, 102, 1518, 10.1016/j.amjcard.2008.07.043
Solano, 2004, Incidence, diagnostic yield and safety of the implantable loop-recorder to detect the mechanism of syncope in patients with and without structural heart disease, Eur Heart J, 25, 1116, 10.1016/j.ehj.2004.05.013
Brignole, 2006, International Study on Syncope of Uncertain Etiology (ISSUE) 2 Group. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope, Eur Heart J, 27, 1085, 10.1093/eurheartj/ehi842
Brignole, 2012, Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial, Circulation, 125, 2566, 10.1161/CIRCULATIONAHA.111.082313
Brignole, 2014, Benefit of pacemaker therapy in patients with presumed neurally mediated syncope and documented asystole is greater when tilt test is negative: an analysis from the third International Study on Syncope of Uncertain Etiology (ISSUE-3), Circ Arrhythm Electrophysiol, 7, 10, 10.1161/CIRCEP.113.001103
Sutton, 2012, Key challenges in the current management of syncope, Nat Rev Cardiol, 9, 590, 10.1038/nrcardio.2012.102
Kuriachan, 2008, Evidence-based treatment for vasovagal syncope, Heart Rhythm, 5, 1609, 10.1016/j.hrthm.2008.08.023
Vyas, 2013, Are treatments for vasovagal syncope effective? A meta-analysis, Int J Cardiol, 167, 1906, 10.1016/j.ijcard.2012.04.144
Brignole, 2003, Management of syncope referred urgently to general hospitals with and without syncope units, Europace, 5, 293, 10.1016/S1099-5129(03)00047-3
Sutton, 2013, Treatment of reflex syncope, J Med Diagn Meth, 2
Krediet, 2002, Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing, Circulation, 106, 1684, 10.1161/01.CIR.0000030939.12646.8F
Brignole, 2002, Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope, J Am Coll Cardiol, 40, 2053, 10.1016/S0735-1097(02)02683-9
van Dijk, 2006, PC-Trial Investigators. Effectiveness of physical counter pressure maneuvers in preventing vasovagal syncope: the Physical Counter pressure Manoeuvres Trial (PC-Trial), J Am Coll Cardiol, 48, 1652, 10.1016/j.jacc.2006.06.059
Madrid, 2001, Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study, J Am Coll Cardiol, 37, 554, 10.1016/S0735-1097(00)01155-4
Sheldon, 2012, Age-dependent effect of beta-blockers in preventing vasovagal syncope, Circ Arrhythm Electrophysiol, 5, 920, 10.1161/CIRCEP.112.974386
Salim, 2005, Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double-blind, placebo-controlled, randomized trial, J Am Coll Cardiol, 45, 484, 10.1016/j.jacc.2004.11.033
Romme, 2011, Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial), Europace, 13, 1639, 10.1093/europace/eur200
Samniah, 2001, Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope, Am J Cardiol, 88, 80, 10.1016/S0002-9149(01)01594-6
Perez-Lugones, 2001, Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study, J Cardiovasc Electrophysiol, 12, 935, 10.1046/j.1540-8167.2001.00935.x
Ward, 1998, Midodrine: a role in the management of neurocardiogenic syncope, Heart, 79, 45, 10.1136/hrt.79.1.45
Qingyou, 2006, The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope, J Pediatr, 149, 777, 10.1016/j.jpeds.2006.07.031
Raj, 2012, Rationale for the prevention of syncope trial IV: assessment of midodrine, Clin Auton Res, 22, 275, 10.1007/s10286-012-0167-5
Theodorakis, 2006, Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study, Europace, 8, 193, 10.1093/europace/euj041
Takata, 2002, Serotonin reuptake inhibitor (Paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers, Circulation, 106, 1500, 10.1161/01.CIR.0000029748.94931.96
Di Girolamo, 1999, Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study, J Am Coll Cardiol, 33, 1227, 10.1016/S0735-1097(98)00694-9
Connolly, 1999, The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope, J Am Coll Cardiol, 33, 16, 10.1016/S0735-1097(98)00549-X
Sutton, 2000, Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators, Circulation, 102, 294, 10.1161/01.CIR.102.3.294
Ammirati, 2001, Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial, Circulation, 104, 52, 10.1161/hc2601.091708
Connolly, 2003, Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial, JAMA, 289, 2224, 10.1001/jama.289.17.2224
Raviele, 2004, Vasovagal Syncope and Pacing Trial Investigators. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE), Eur Heart J, 25, 1741, 10.1016/j.ehj.2004.06.031
Sud, 2007, Implications of mechanism of bradycardia on response to pacing in patients with unexplained syncope, Europace, 9, 312, 10.1093/europace/eum020
Deharo, 2013, Syncope without prodromes in patients with normal heart and normal electrocardiogram: a distinct entity, J Am Coll Cardiol, 62, 1075, 10.1016/j.jacc.2013.05.060
Brignole, 2011, Syncope due to idiopathic paroxysmal atrioventricular block: long-term follow-up of a distinct form of atrioventricular block, J Am Coll Cardiol, 58, 167, 10.1016/j.jacc.2010.12.045
Flammang, 2012, Treatment of unexplained syncope: a multicenter, randomized trial of cardiac pacing guided by adenosine 5’-triphosphate testing, Circulation, 125, 31, 10.1161/CIRCULATIONAHA.111.022855
McLeod, 1999, Cardiac pacing for severe childhood neurally mediated syncope with reflex anoxic seizures, Heart, 82, 721, 10.1136/hrt.82.6.721
Plash, 2013, Diagnosing postural tachycardia syndrome: comparison of tilt testing compared with standing haemodynamics, Clin Sci, 124, 109, 10.1042/CS20120276
Colivicchi, 2002, Exercise-related syncope in young competitive athletes without evidence of structural heart disease. Clinical presentation and long-term outcome, Eur Heart J, 23, 1125, 10.1053/euhj.2001.3042
Ross, 2013, What is brain fog? An evaluation of the symptom in postural tachycardia syndrome, Clin Auton Res, 23, 305, 10.1007/s10286-013-0212-z
Chen, 2011, Midodrine hydrochloride is effective in the treatment of children with postural orthostatic tachycardia syndrome, Circ J, 75, 927, 10.1253/circj.CJ-10-0514
Zhang, 2008, Randomized comparison of metoprolol versus conventional treatment in preventing recurrence of vasovagal syncope in children and adolescents, Med Science Monitor, 14, CR199